SREBF1 and cancer: HCC cells predominantly rely on de novo lipogenesis (DNL) for energy metabolism, characterized by the synergistic activation of sterol regulatory element-binding protein 1 (SREBP1) and fatty acid synthase (FASN), which drives the synthesis of saturated fatty acids to fuel abnormal cancer cell proliferation.